Literature DB >> 22162537

Clarification on precision criteria to derive sample size when designing pediatric pharmacokinetic studies.

Yaning Wang1, Pravin R Jadhav, Mallika Lala, Jogarao V Gobburu.   

Abstract

Mesh：

Year:  2011        PMID： 22162537     DOI： 10.1177/0091270011422812

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  33 in total

1.  Renal Clearance in Newborns and Infants: Predictive Performance of Population-Based Modeling for Drug Development.

Authors:  Jian Wang; Shaun S Kumar; Catherine M Sherwin; Robert Ward; Gerri Baer; Gilbert J Burckart; Yaning Wang; Lynne P Yao
Journal:  Clin Pharmacol Ther       Date:  2019-02-10       Impact factor: 6.875

2.  Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.

Authors:  Vidya Chidambaran; Raja Venkatasubramanian; Senthilkumar Sadhasivam; Hope Esslinger; Shareen Cox; Jeroen Diepstraten; Tsuyoshi Fukuda; Thomas Inge; Catherijne A J Knibbe; Alexander A Vinks
Journal:  Paediatr Anaesth       Date:  2015-05-13       Impact factor: 2.556

3.  Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Kana Mizuno; Min Dong; Tsuyoshi Fukuda; Sharat Chandra; Parinda A Mehta; Scott McConnell; Elias J Anaissie; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

Review 4.  A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms.

Authors:  Anne Zajicek; Michael J Fossler; Jeffrey S Barrett; Jeffrey H Worthington; Robert Ternik; Georgia Charkoftaki; Susan Lum; Jörg Breitkreutz; Mike Baltezor; Panos Macheras; Mansoor Khan; Shreeram Agharkar; David Douglas MacLaren
Journal:  AAPS J       Date:  2013-08-02       Impact factor: 4.009

5.  Validation of a pediatric population pharmacokinetic model for vancomycin.

Authors:  Andrea Hahn; Robert W Frenck; Yuanshu Zou; Alexander A Vinks
Journal:  Ther Drug Monit       Date:  2015-06       Impact factor: 3.681

6.  Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel.

Authors:  Hoai-Thu Thai; Florent Mazuir; Sylvaine Cartot-Cotton; Christine Veyrat-Follet
Journal:  Br J Clin Pharmacol       Date:  2015-08-14       Impact factor: 4.335

7.  Clinical Trial Simulations and Pharmacometric Analysis in Pediatrics: Application to Inhaled Loxapine in Children and Adolescents.

Authors:  Min Dong; Tsuyoshi Fukuda; Sally Selim; Mark A Smith; Laura Rabinovich-Guilatt; James V Cassella; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447

8.  The integration of allometry and virtual populations to predict clearance and clearance variability in pediatric populations over the age of 6 years.

Authors:  Andrea N Edginton; Bhavank Shah; Michael Sevestre; Jeremiah D Momper
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

9.  Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.

Authors:  Jason R Wiles; Barbara Isemann; Tomoyuki Mizuno; Meredith E Tabangin; Laura P Ward; Henry Akinbi; Alexander A Vinks
Journal:  J Pediatr       Date:  2015-09-11       Impact factor: 4.406

10.  Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study.

Authors:  Victoria C Ziesenitz; Frédérique Rodieux; Andrew Atkinson; Carole Borter; Julia A Bielicki; Manuel Haschke; Urs Duthaler; Fabio Bachmann; Thomas O Erb; Nicolas Gürtler; Stefan Holland-Cunz; Johannes N van den Anker; Verena Gotta; Marc Pfister
Journal:  Eur J Clin Pharmacol       Date:  2019-08-07       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.